Skip to content
OpenCapital
Get started

ADMA Biologics ADMA ADMA Bio Manufacturing — D&A

Other segment segments

Plasma Collection Centers
$565K-30.1%

Similar metrics at other companies

The Greenbrier Companies logo
GBXManufacturing — D&A
$20.8M+7.2%
OTT
OTTRManufacturing — D&A
$4.79M-11.7%
Huntsman logo
HUNAdvanced Materials — D&A
$12M-7.7%
Celanese Corporation logo
CEEngineered Materials — D&A
$107M-1.8%
Chemours logo
CCAdvanced Performance Materials — D&A
$23M-34.3%
OSI Systems logo
OSISOptoelectronics And Manufacturing Division — D&A
$1.79M+9.9%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's adma bio manufacturing — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's ADMA bio manufacturing — D&A?
ADMA Biologics (ADMA) reported ADMA bio manufacturing — D&A of $1.27M in Q1 2026.
How has ADMA Biologics's ADMA bio manufacturing — D&A changed year-over-year?
ADMA Biologics's ADMA bio manufacturing — D&A increased by 9.7% year-over-year, from $1.16M to $1.27M.
What is the long-term trend for ADMA Biologics's ADMA bio manufacturing — D&A?
Over 3 years (2021 to 2024), ADMA Biologics's ADMA bio manufacturing — D&A has grown at a -4.2% compound annual growth rate (CAGR), from $4.22M to $3.71M.
What does ADMA bio manufacturing — D&A mean?
Represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the manufacturing segment. It provides insight into the capital intensity of the segment's infrastructure and production facilities.